Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01449721 · ClinicalTrials.gov registry record · NA
Preemptive Resuscitation for Eradication of Septic Shock
A NA study of Sepsis and Severe Sepsis, sponsored by Christiana Care Health Services.
- Completed
- Registry status
- NA
- Development phase
- 142
- Enrollment target
- 5
- Study locations
NCT01449721 is a NA study of Sepsis and Severe Sepsis that has completed, run by Christiana Care Health Services. The registered enrollment target is 142 participants, below the 6,563-participant average among 90 other Sepsis trials with a reported enrollment target (98% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT01449721, a NA study of Sepsis and Severe Sepsis, has completed, sponsored by Christiana Care Health Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 142 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to assess the ability of an empiric resuscitation strategy compared to standard care to decrease the incidence of organ failure in normotensive sepsis patients.
Conditions Studied
Interventions
- DRUG Intravenous fluid
Study Locations (5)
Delaware
- Christiana Care Health System - Newark
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Michigan
- Detroit Receiving Hospital/University Health Center - Detroit
Mississippi
- University of Mississippi Medical Center - Jackson
New Jersey
- Cooper University Hospital:Cooper Medical School of Rowan University - Camden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2011-09 |
| Est. Completion | 2016-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01449721
The ClinicalTrials.gov registry entry for NCT01449721 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,563-participant average among 90 other Sepsis trials with a reported enrollment target (98% lower). The listed sponsor is Christiana Care Health Services, which has 82 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sepsis appearing as the primary indexed condition, and to 1 intervention - of which Intravenous fluid is the first listed.
NCT01449721 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Delaware, Massachusetts, Michigan.
Frequently Asked Questions
What is clinical trial NCT01449721 about?
NCT01449721 is a clinical study titled "Preemptive Resuscitation for Eradication of Septic Shock". The purpose of this study is to assess the ability of an empiric resuscitation strategy compared to standard care to decrease the incidence of organ failure in normotensive sepsis patients.
What is the current status of trial NCT01449721?
This trial is currently completed. It is a NA study. The enrollment target is 142 participants. The study started on 2011-09. Estimated completion is 2016-01.
What conditions does trial NCT01449721 study?
This clinical trial studies the following conditions: Sepsis, Severe Sepsis.
What interventions are being tested in trial NCT01449721?
The interventions under investigation include: Intravenous fluid (DRUG).
Who is sponsoring clinical trial NCT01449721?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01449721 being conducted?
This trial has 5 study locations across Delaware, Massachusetts, Michigan, Mississippi, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
-
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
RECRUITING · NA
-
BLOOM: Pragmatic Feasibility Trial
RECRUITING · NA
-
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
RECRUITING · NA
-
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.